NCT01973283View on ClinicalTrials.gov

Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 19, 2014

Primary Completion Date

December 5, 2019

Study Completion Date

December 5, 2020

Conditions
Major Depressive DisorderDysthymic DisorderDepressive Disorder, NOS
Interventions
DRUG

Antidepressant Medication

If patient has a history of non-response or cannot tolerate escitalopram and/or duloxetine, then they will be treated openly with an approved antidepressant.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT01973283 - Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults | Biotech Hunter | Biotech Hunter